PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33330868-0	2021	Binding of SARS-CoV-2 spike protein to ACE2 is disabled by thiol-based drugs; evidence from in vitro SARS-CoV-2 infection studies.	Sulfhydryl Compounds	59-64	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	22-27	
33330868-4	2021	We found that thiol-based drugs, cysteamine and WR-1065 (the active metabolite of amifostine) in particular, decrease binding of SARS-CoV-2 spike protein to its receptor, decrease the entry efficiency of SARS-CoV-2 spike pseudotyped virus, and inhibit SARS-CoV-2 live virus infection.	Sulfhydryl Compounds	14-19	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	140-145	
33330868-4	2021	We found that thiol-based drugs, cysteamine and WR-1065 (the active metabolite of amifostine) in particular, decrease binding of SARS-CoV-2 spike protein to its receptor, decrease the entry efficiency of SARS-CoV-2 spike pseudotyped virus, and inhibit SARS-CoV-2 live virus infection.	Sulfhydryl Compounds	14-19	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	215-220	
33330868-6	2021	One Sentence Summary: Thiol-based drugs decrease binding of SARS-CoV-2 spike protein to its receptor and inhibit SARS-CoV-2 cell entry.	Sulfhydryl Compounds	22-27	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	71-76